{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:07:01Z","timestamp":1783444021806,"version":"3.54.6"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Optic neuritis usually leads to reduced color sensitivity. Most often, the change of red color, the so-called red desaturation, is tested in clinical routine. The aim of this study was to test the feasibility of the Reddesa chart, a new red desaturation test based on polarization, as a screening method for optic neuropathy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 20 patients with unilateral optic neuritis and 20 healthy controls were included in this prospective pilot study. Ophthalmological examination included assessment of best corrected visual acuity (BCVA), slit lamp examination, fundoscopy, testing of relative afferent pupillary defect (RAPD) and red desaturation with the red cup test and the Reddesa chart.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean BCVA in the optic neuritis group was 0.76 \u00b1 0.36 in the affected eye (95% of eyes with RAPD, 75% of eyes with difference in the Reddesa test) and 1.28 \u00b1 0.24 in the healthy eye, whereas in the control group, BCVA was 1.14 \u00b1 0.11 in the right eye and 1.15 \u00b1 0.14 in the left eye (none of the eyes with RAPD or abnormal Reddesa test). In our study, the Reddesa test showed a positive predictive value of 100% and a negative predictive value of 80% for detecting optic neuritis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The Reddesa chart allows to quantify red desaturation and has the potential to be implemented as a screening test in clinical routine.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.898064","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T09:26:07Z","timestamp":1657185967000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of the Reddesa Chart, a New Red Desaturation Testing Method, for Optic Neuritis Screening and Grading in Clinical Routine"],"prefix":"10.3389","volume":"13","author":[{"given":"Dominik","family":"Bruegger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lucia","family":"Koth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Dysli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Abegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Tschopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Tappeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","volume":"109","year":"1991","journal-title":"Arch Ophthalmol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/jamaneurol.2020.3502","article-title":"Trends in optic neuritis incidence and prevalence in the UK and association with systemic and neurologic disease","volume":"77","author":"Braithwaite","year":"2020","journal-title":"JAMA Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1055\/s-0035-1545771","article-title":"Optikusneuritis nach Grippeimpfung bei einer Patientin nach Stammzelltransplantation","volume":"232","author":"J\u00f6hr","year":"2015","journal-title":"Klin Monatsbl Augenheilkd."},{"key":"B4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1212\/WNL.45.2.244","article-title":"Optic neuritis: a population-based study in olrnsted county, Minnesota","volume":"45","author":"Rodriguez","year":"1995","journal-title":"Neurology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1001\/archopht.1972.01000020137004","article-title":"Optic neuritis and multiple sclerosis: an epidemiologic study","volume":"87","author":"Percy","year":"1972","journal-title":"Arch Ophthalmol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajo.2020.07.014","article-title":"Population-based incidence of optic neuritis in the era of aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies","volume":"220","author":"Hassan","year":"2020","journal-title":"Am J Ophthalmol."},{"key":"B7","first-page":"2278","article-title":"Color vision defect type and spatial vision in the optic neuritis treatment trial","volume":"38","author":"Schneck","year":"1997","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0002-9394(14)76811-4","article-title":"Acquired Color Vision Defects in Retrobulbar Neuritis","volume":"86","author":"Griffin","year":"1978","journal-title":"Am J Ophthalmol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/brain\/112.2.283","article-title":"Spatiotemporal contrast sensitivity and colour vision in multiple sclerosis","volume":"112","author":"Travis","year":"1989","journal-title":"Brain."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/CPJ.0000000000001011","article-title":"Red desaturation prevalence and severity in healthy patients","volume":"12","author":"Mikolajczyk","year":"2020","journal-title":"Neurol Clin Pract."},{"key":"B11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/jamaophthalmol.2017.5470","article-title":"Incidence and causes of overdiagnosis of optic neuritis","volume":"136","author":"Stunkel","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ajo.2015.06.015","article-title":"Clinical color vision testing and correlation with visual function","volume":"160","author":"Zhao","year":"2015","journal-title":"Am J Ophthalmol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.898064\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T09:26:11Z","timestamp":1657185971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.898064\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":12,"alternative-id":["10.3389\/fneur.2022.898064"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.898064","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"article-number":"898064"}}